身体活动对慢性广泛疼痛的影响:从元分析和双样本孟德尔随机化中的见解
Chongjie Yao1,2,3, Yuchen Zhang2,3, Sizheng Steven Zhao4
1Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, People's Republic of China.
Journal of pain research
|March 20, 2025
概括
身体活动 (PA) 有效地治疗慢性广泛疼痛 (CWP) 和纤维肌痛症状. 高强度运动和三个月的持续时间显示了对疼痛,抑郁和生活质量最显著的益处.
科学领域:
- 类风湿病学 类风湿病学
- 运动医学 运动医学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 慢性广泛疼痛 (CWP) 是影响健康的关键纤维肌痛症状.
- 建议进行体力活动 (PA),但缺乏标准化处方.
- 本研究研究了PA在CWP预防和治疗中的作用,考虑了模式,持续时间和强度.
研究的目的:
- 研究身体活动 (PA) 对慢性普遍疼痛 (CWP) 的影响.
- 分析PA模式,治疗持续时间和强度如何影响CWP结果.
- 结合临床和遗传证据,全面了解PA在CWP管理中的有效性.
主要方法:
- 对10个数据库 (2014年1月至2024年7月) 进行系统审查,包括针对CWP/纤维肌痛的PA的随机对照试验.
- 用固定或随机效应模型对11项研究 (540名参与者) 的元分析.
- 门德尔随机化 (MR) 分析,以评估PA强度和CWP风险之间的遗传联系.
主要成果:
- 通过PA干预可显著改善疼痛感知 (MD:-1.47),抑郁 (MD:-4.77),以及生活质量 (SMD:-1.43).
- MR 分析表明,各种 PA 强度,包括步行,DIY 活动和劳累性体育运动,与 CWP 易感性降低有关.
- 特定的PA强度,如快乐步行 (OR:0.950) 和艰苦的运动 (OR:0.923) 显示出保护作用.
结论:
- 对于CWP患者来说,PA干预有益,改善疼痛,情绪和生活质量.
- 建议治疗时间大约为三个月,Ba-Duan-Jin显示出潜在的有效性.
- 高强度的PA显示出对CWP的最显著的保护作用.
相关概念视频
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
Analgesia and Pain Management
415
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
415


